The world is entering a new era of vaccines. Following the success of COVID-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus’s structure, putting a host of new vaccines on the horizon. The most recent arrivals are several new immunizations against respiratory syncytial virus, or RSV. These shots are … Read more
Alzheimer’s patients now have more options than ever for treating their disease— two drugs are approved to treat the causes of Alzheimer’s, and the U.S. Food and Drug Administration is currently considering approving another, which could be available next year. Many researchers are starting to focus on how to get the most out of these … Read more
The crisis should command more of Mayor Muriel E. Bowser’s attention, advocates said, as a commission assesses how to use $80 million in opioid settlement money. View original article Contributor: Jenna Portnoy
The funding delays are the latest complication facing PEPFAR, a life-saving program that has been ensnared in a broader political fight around abortion. View original article Contributor: Dan Diamond
NICHD Research Profiles: Text Alternative | NICHD – Eunice … National Institute of Child Health and Human Development >View original article Contributor:
Flu and COVID-19 can be unpleasant for most people, but if you’re pregnant, it’s particularly important to get vaccinated to protect both you and your baby. We recommend that all pregnant women get flu and COVID-19 vaccines in the coming weeks as part of the winter vaccination campaign, no matter what stage of pregnancy they’re … Read more
Dry Eye Syndrome | OPTH Dove Medical Press >View original article Contributor:
Alternative Break: Expand Horizons in Mental Health with the … James Madison University >View original article Contributor:
PEPFAR, created by President George W. Bush in 2003 to combat the disease, faces an uncertain future now that its authorizing legislation has lapsed. View original article Contributor: Sheryl Gay Stolberg
The agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease. View original article Contributor: Sabrina Malhi